Skip to content. | Skip to navigation

Personal tools
Sections
You are here: Home topics Health
Document Actions

Public Health Policy in the EU

Latest news on the public health policy of the European Union.

New EU pharma strategy to make medicines affordable
A new pharmaceutical strategy, adopted Wednesday by the EU Commission, offers patients access to affordable medicines and supports competitiveness and innovation in Europe's pharma industry.

A Pharmaceutical Strategy for Europe - guide
The European Commission adopted on 25 November a Pharmaceutical Strategy for Europe to ensure patients have access to innovative and affordable medicines and to support the competitiveness, innovative capacity and sustainability of the EU's pharmaceutical industry.

G20 leaders agree to make Covid vaccines available and affordable for all
At the weekend summit of the G20 countries, leaders expressed a commitment to coordinated global action to fight the COVID-19 pandemic, and support for the most vulnerable and fragile countries.

EU leaders to step up pandemic coordination
EU leaders agreed Thursday to strengthen coordination on combating the COVID-19 pandemic, with a focus on mutual recognition of tests, vaccine deployment and a common approach to lifting restrictive measures.

EU Court rules against French ban on marketing CBD
The European Court of Justice ruled Thursday against France's ban on the marketing of wholly hemp-derived cannabidiol (CBD), when it has been lawfully produced in another EU Member State.

EU states receive EUR 14 bn pandemic help
As the second COVID wave hits Europe hard, the EU Commission Tuesday disbursed some EUR 14 billion to nine EU countries in the second instalment of loans to help finance short-time work schemes.

EU approves BioNTech -Pfizer contract for access to vaccine
The Commission approved a fourth contract with pharmaceutical companies BioNTech and Pfizer Wednesday, providing for an initial purchase of 200 million doses on behalf of all EU Member States.

Biden victory offers businesses greater stability and hope on COVID-19 and immigration
Expert comment from Christian Stadler, Professor of Strategic Management at Warwick Business School:

EU leaders strengthen resolve as 2nd Covid wave hits Europe
EU leaders at a summit Thursday resolved to strengthen their collective effort to fight the COVID-19 pandemic, with a focus on testing and tracing policies, and on vaccines.

EU SURE social bonds first issue
The European Commission issued a EUR 17 billion inaugural social bond on 21 October under the EU SURE instrument to help protect jobs and keep people in work.

Coordination of measures restricting free movement in the EU related to the coronavirus pandemic
The EU Council agreed on 13 October on EU-wide coordination of measures restricting free movement related to the coronavirus pandemic.

EU states look to coordinate COVID travel measures
The EU adopted Tuesday a common framework on travel measures in response to the COVID-19 pandemic, with recommendations to help states take decisions based on the epidemiological situation region by region.

EUR 87.4 bn to support workers through COVID-19
The EU Council approved Friday financial support of EUR 87.4 bn to 16 Member States in the form of EU loans under SURE - a temporary EU instrument to mitigate unemployment risks during the COVID-19 crisis.

SURE - the temporary Support to mitigate Unemployment Risks in an Emergency
The temporary Support to mitigate Unemployment Risks in an Emergency (SURE) is available for Member States that need to mobilise significant financial means to fight the negative economic and social consequences of the coronavirus outbreak on their territory. It can provide financial assistance up to EUR 100 billion in the form of loans from the EU to affected Member States to address sudden increases in public expenditure for the preservation of employment.

Record levels of cocaine in Europe: EU drugs agency
Increase in cocaine availability with seizures at a record high, a near doubling of heroin seizures and high availability of high purity drugs are the stand-out points of the European Drug Report published Tuesday.

Brussels to improve workers' protection against cancer-causing chemicals
The EU Commission proposed a new revision of the Carcinogens and Mutagens Directive Tuesday, with new or revised limit values limiting workers' exposure to three important cancer-causing chemicals.

Improved protection against cancer for workers
To improve workers' protection against cancer, the European Commission proposed on 22 September to further limit their exposure to cancer-causing chemicals.

MEPs approve EUR 6.2 bn to tackle crisis, speed up vaccine deployment
The EU Parliament gave the go-ahead to an increase in the EU budget of EUR 6.2 billion Thursday, to improve the chances of an effective and safe vaccine, and to step up COVID-19-related cohesion funding.

EU forecasts big increase in VAT gap due to coronavirus
Forecasts for 2020 VAT revenues to EU Member States show a potential loss in the region of EUR 164 billion due to effects of the coronavirus pandemic on the economy, as well as fraud and tax evasion.

Poor environment causes one in eight deaths in Europe
Heatwaves, air and noise pollution contribute to 13 per cent of all deaths in Europe, according to a major assessment on health and environment released Tuesday the EU Environment Agency (EEA).

Brussels signs first contract with AstraZeneca
The first pharmaceutical contract negotiated by the EU Commission on behalf of EU Member States entered into force Thursday following the formal signature between AstraZeneca and the Commission.

Brussels concludes talks with fifth vaccine manufacturer
The EU concluded exploratory talks with U.S. based company Moderna Monday to purchase a potential vaccine against COVID-19 - the fifth company with which the Commission has concluded talks.

Europe readies EUR 81.4 bn to mitigate effects of pandemic
The European Commission presented proposals Monday for financial support of some of EUR 81 billion to 15 EU Member States to help protect jobs and workers affected by the coronavirus pandemic.

New talks with CureVac expand EU portfolio of future vaccines
The EU Commission concluded Thursday exploratory talks with CureVac to purchase a potential vaccine against COVID-19, offering the possibility for all EU Member States to purchase the vaccine.

European Vaccines Strategy
As part of the effort to help protect people everywhere and EU citizens in particular, the Commission is proposing an EU strategy to accelerate the development, manufacturing, and deployment of vaccines against COVID-19. COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE EUROPEAN COUNCIL, THE COUNCIL AND THE EUROPEAN INVESTMENT BANK EU Strategy for COVID-19 vaccines - COM/2020/245 final